Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study.

Fournier JP, Lapeyre-Mestre M, Sommet A, Dupouy J, Poutrain JC, Montastruc JL.

PLoS One. 2012;7(3):e34187. doi: 10.1371/journal.pone.0034187. Epub 2012 Mar 27.

2.

Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.

Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R.

Pharmacoepidemiol Drug Saf. 2007 Jan;16(1):55-64.

PMID:
16470693
3.

An investigation of the concomitant use of angiotensin-converting enzyme inhibitors, non-steroidal anti-inflammatory drugs and diuretics.

Bucsa C, Moga DC, Farcas A, Mogosan C, Dumitrascu DL.

Eur Rev Med Pharmacol Sci. 2015 Aug;19(15):2938-44.

5.

More on the "Triple Whammy": antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury - a case/non-case study in the French pharmacovigilance database.

Fournier JP, Sommet A, Durrieu G, Poutrain JC, Lapeyre-Mestre M, Montastruc JL; French Network of Regional Pharmacovigilance Centres.

Ren Fail. 2014 Aug;36(7):1166-8. doi: 10.3109/0886022X.2014.917943. Epub 2014 May 15.

PMID:
24826803
6.

Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database.

Fournier JP, Sommet A, Durrieu G, Poutrain JC, Lapeyre-Mestre M, Montastruc JL; French Network of Regional Pharmacovigilance Centres.

Fundam Clin Pharmacol. 2014 Apr;28(2):230-5. doi: 10.1111/fcp.12014. Epub 2012 Nov 28.

PMID:
23190210
7.

Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease.

Wang PT, Huang YB, Lin MY, Chuang PF, Hwang SJ.

Kaohsiung J Med Sci. 2012 Sep;28(9):477-83. doi: 10.1016/j.kjms.2012.04.004. Epub 2012 Jul 7.

8.

Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: a population-based cohort study.

Fournier JP, Sommet A, Bourrel R, Oustric S, Pathak A, Lapeyre-Mestre M, Montastruc JL.

Eur J Clin Pharmacol. 2012 Nov;68(11):1533-40. doi: 10.1007/s00228-012-1283-9. Epub 2012 Apr 15.

PMID:
22527348
9.

Study of the use of a spironolactone and angiotensin-converting enzyme inhibitor combination: a population-based analysis.

Besançon JF, Lagarce L, Diquet B, Lainé-Cessac P.

Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):172-9.

PMID:
17948926
10.

Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?

Raebel MA, McClure DL, Chan KA, Simon SR, Feldstein AC, Lafata JE, Andrade SE, Gunter MJ, Nelson WW, Roblin D, Platt R.

Ann Pharmacother. 2007 Feb;41(2):193-200. Epub 2007 Feb 6.

PMID:
17284506
11.

Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.

Petrella R, Michailidis P.

Clin Ther. 2011 Sep;33(9):1190-203. doi: 10.1016/j.clinthera.2011.08.008. Epub 2011 Sep 1.

PMID:
21885126
12.
13.

Hyperkalemia and renal function during monotherapy and dual renin-angiotensin blockade in the community setting.

Kurnik D, Vesterman-Landes J, Bialik M, Katzir I, Lomnicky Y, Halkin H, Loebstein R.

Clin Ther. 2011 Apr;33(4):456-64. doi: 10.1016/j.clinthera.2011.04.011.

PMID:
21635991
14.

Exposure of the elderly to potential nephrotoxic drug combinations in Belgium.

Smets HL, De Haes JF, De Swaef A, Jorens PG, Verpooten GA.

Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):1014-9. doi: 10.1002/pds.1641.

PMID:
18763247
16.

Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension.

Aljadhey H, Tu W, Hansen RA, Blalock SJ, Brater DC, Murray MD.

BMC Cardiovasc Disord. 2012 Oct 24;12:93. doi: 10.1186/1471-2261-12-93.

17.
18.

Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.

Hogan DB, Campbell NR, Crutcher R, Jennett P, MacLeod N.

CMAJ. 1994 Aug 1;151(3):315-22.

19.
20.

How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?

Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D.

J Card Fail. 2004 Aug;10(4):297-303.

PMID:
15309695

Supplemental Content

Support Center